BBHvsFTXHETF Comparison
VanEck Biotech ETF (BBH) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. BBH is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.6% for FTXH. BBH is down -1.86% year-to-date (YTD) with -$4M in YTD flows. FTXH performs better with 2.18% YTD performance, and +$9M in YTD flows. Run a side-by-side ETF comparison of BBH and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BBH vs FTXH performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBH FTXH | +1.88%+1.62% | -7.18%-0.72% | -1.86%+2.18% | +24.34%+36.04% | +15.09%+30.54% | -0.59%+36.84% |
| Flows | BBH FTXH | -$2M+$2M | -$4M+$7M | -$4M+$9M | -$52M+$11M | -$188M-$7M | -$130M+$3M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBH FTXH | +20.75%+17.61% | +20.44%+18.13% | +18.72%+16.09% | +21.44%+15.80% |
| Max drawdown | BBH FTXH | -10.45%-7.50% | -10.45%-7.50% | -22.78%-19.32% | -39.88%-19.32% |
| Max drawdown duration | BBH FTXH | 87d54d | 87d54d | 440d393d | 1719d393d |
BBH | FTXH | |
Last sale 4/27/2026 at 1:30 PM | $184.16 | $33.64 |
| Previous close 04/24/2026 | $185.67 | $34.01 |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBH | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBH | FTXH | |
|---|---|---|
| Last price | $184.16 | $33.64 |
| 1D performance | -0.81% | -1.10% |
| AuM | $365.13 M | $30.23 M |
| E/R | 0.35% | 0.6% |
BBH | FTXH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VanEck | First Trust |
| Benchmark | MVIS US Listed Biotech 25 Index | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 21 | 50 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | September 20, 2016 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
